LAMATTINA JOHN L bought LGND

November 7, 2025 · Form 4 insider transaction

LAMATTINA JOHN L bought 2,145 shares of Ligand Pharmaceuticals Incorporated at $66.13 per share, a transaction worth $141.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.